Médicaments de l’ostéolyse tumorale

Abstract

Malignant tumour osteolysis is a frequent complication of cancers and multiple myeloma. It can cause skeletal related-events including pathological fractures, spinal cord compression, bone pain or hypercalcemia, with a significant alteration of quality of life and survival. Bisphosphonates (BP) play an important role in the management of this malignant… (More)
DOI: 10.1007/s10269-008-0992-2

Topics

Cite this paper

@article{Debiais2008MdicamentsDL, title={M{\'e}dicaments de l’ost{\'e}olyse tumorale}, author={Françoise Debiais and Carine Martin}, journal={Oncologie}, year={2008}, volume={11}, pages={16-21} }